Point Biopharma Global
(NASDAQ) PNT
This security has been delisted. This page is retained for historical reference.
PNT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowPNT Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
55.40%
Net Income Margin
43.38%
Return on Equity
26.49%
Return on Capital
25.78%
Return on Assets
17.00%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$9.69B
Operating Income
$107.77M
EBITDA
-$6.07B
Operating Cash Flow
$112.06M
Capital Expenditure
-$19.32M
Free Cash Flow
$92.74M
Cash & ST Invst.
$339.16M
Total Debt
$10.66M
Point Biopharma Global Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.79M
N/A
Gross Profit
$2.79M
N/A
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
129
N/A
Net Income
-$24.77M
-3.2%
EBITDA
-$34.49M
-43.7%
Quarterly Fundamentals
Total Cash
$339.16M
+16.3%
Total Debt
$10.66M
N/A
Accounts Receivable
$9.39M
+5434.9%
Inventory
$4.20M
N/A
Long Term Debt
$8.74M
N/A
Short Term Debt
$1.93M
N/A
Return on Assets
17.00%
N/A
Return on Invested Capital
25.18%
N/A
Free Cash Flow
-$34.53M
-15.3%
Operating Cash Flow
-$28.13M
-26.0%